Search
for
Sort by
Research 721–750 of 1000+
- Avaliação da pele e cabelos oleosos, desenvolvimento e eficácia clínica de formulações cosméticas contendo extrato de guaraná
- PLATELET RİCH PLASMA RESULTS IN THE TREATMENT OF FEMUR HEAD AVASCULAR NECROSIS
- EFFECTS OF LIRAGLUTIDE ON VISCERAL ADIPOSITY INDEX IN WOMAN OF REPRODUCTIVE AGE WITH PREDIABETES
- British Society for Dermatopathology
- Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID‐19
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Effects of oxytocin on the hair growth ability of dermal papilla cells
- COVID‐19 and cutaneous manifestations: A review of the published literature
- Alopecia in patients with COVID-19: A systematic review and meta-analysis
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- Peppermint essential oil nanoliposomes: Innovative formulation for effective hair growth
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- COVID‐19 and dermatology: a comprehensive guide for dermatologists
- Investigating Biochemical Biomarkers in Telogen Effluvium Post-COVID-19 Patients: A Retrospective Cohort Study
- Alopecia areata following COVID-19 vaccine: a systematic review
- The impact of SARS-CoV-2 and COVID-19 on male reproduction and men’s health
- Prevalence and Predictors of Premature Graying of Hair Before the Age of 30: A Cross‐Sectional Study in Saudi Arabia
- The Role of Neurorehabilitation in Post-COVID-19 Syndrome
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Retrospective Evaluation of the Impact of the COVID-19 Pandemic on the Incidence of Alopecia Areata in a Single Dermatological Department
- Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease
- Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study
- Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
- Hair Disorders
- Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata